| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |